These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24269995)

  • 21. Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.
    Raksayot M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Treeprasertsuk S; Poovorawan Y; Tanaka Y; Tangkijvanich P
    J Gastroenterol; 2019 May; 54(5):427-436. PubMed ID: 30506232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
    Kim HS; Xiao X; Byun J; Jun G; DeSantis SM; Chen H; Thrift AP; El-Serag HB; Kanwal F; Amos CI
    JAMA Netw Open; 2022 Oct; 5(10):e2234221. PubMed ID: 36190732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis.
    Trepo E; Guyot E; Ganne-Carrie N; Degre D; Gustot T; Franchimont D; Sutton A; Nahon P; Moreno C
    Hepatology; 2012 Apr; 55(4):1307-8. PubMed ID: 22162034
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis.
    Urias E; Tedesco NR; Burkholder DA; Moran IJ; Miller MJ; Jasty VSJ; Patil S; Zoellner S; Wijarnpreecha K; Chen VL
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
    Zampino R; Coppola N; Cirillo G; Boemio A; Pisaturo M; Marrone A; Macera M; Sagnelli E; Perrone L; Adinolfi LE; Miraglia del Giudice E
    J Viral Hepat; 2013 Aug; 20(8):517-23. PubMed ID: 23808989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis.
    Takeuchi Y; Ikeda F; Moritou Y; Hagihara H; Yasunaka T; Kuwaki K; Miyake Y; Ohnishi H; Nakamura S; Shiraha H; Takaki A; Iwasaki Y; Nouso K; Yamamoto K
    J Gastroenterol; 2013 Mar; 48(3):405-12. PubMed ID: 22869157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases.
    Khlaiphuengsin A; Kiatbumrung R; Payungporn S; Pinjaroen N; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(18):8377-82. PubMed ID: 26745088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
    Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J
    Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis.
    Falleti E; Cussigh A; Cmet S; Fabris C; Toniutto P
    Dig Liver Dis; 2016 Jan; 48(1):69-75. PubMed ID: 26493626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population.
    Balasus D; Way M; Fusilli C; Mazza T; Morgan MY; Cervello M; Giannitrapani L; Soresi M; Agliastro R; Vinciguerra M; Montalto G
    Oncotarget; 2016 Dec; 7(52):86791-86802. PubMed ID: 27888630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.
    Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Cirillo G; Grandone A; Salpietro S; Minichini C; Del Giudice EM; Lazzarin A; Sagnelli E; Coppola N
    Clin Microbiol Infect; 2016 Apr; 22(4):372-378. PubMed ID: 26806136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
    Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
    Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-516a-3P, a potential circulating biomarker in hepatocellular carcinoma, correlated with
    Youssef SS; Youness RA; Abbas EAE; Osman NM; ELFiky A; El-Kassas M
    Per Med; 2022 Nov; 19(6):483-493. PubMed ID: 36239555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.
    Valenti L; Motta BM; Soardo G; Iavarone M; Donati B; Sangiovanni A; Carnelutti A; Dongiovanni P; Rametta R; Bertelli C; Facchetti F; Colombo M; Fargion S; Fracanzani AL
    PLoS One; 2013; 8(10):e75982. PubMed ID: 24155878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.
    Viganò M; Valenti L; Lampertico P; Facchetti F; Motta BM; D'Ambrosio R; Romagnoli S; Dongiovanni P; Donati B; Fargion S; Colombo M
    Hepatology; 2013 Oct; 58(4):1245-52. PubMed ID: 23564580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ATG16L1 gene variant rs2241880 (p.T300A) is associated with susceptibility to HCC in patients with cirrhosis.
    Reuken PA; Lutz P; Casper M; Al-Herwi E; Stengel S; Spengler U; Stallmach A; Lammert F; Nischalke HD; Bruns T
    Liver Int; 2019 Dec; 39(12):2360-2367. PubMed ID: 31484215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases.
    Yang J; Trépo E; Nahon P; Cao Q; Moreno C; Letouzé E; Imbeaud S; Gustot T; Deviere J; Debette S; Amouyel P; Bioulac-Sage P; Calderaro J; Ganne-Carrié N; Laurent A; Blanc JF; Guyot E; Sutton A; Ziol M; Zucman-Rossi J; Nault JC
    Int J Cancer; 2019 Feb; 144(3):533-544. PubMed ID: 30289982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.